- Home
- ACHV vs VOXR Comparison
ACHV vs VOXR Comparison
Compare ACHV & VOXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- VOXR
- Stock Information
- Founded
- ACHV N/A
- VOXR 2014
- Country
- ACHV Canada
- VOXR Canada
- Employees
- ACHV N/A
- VOXR N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- VOXR Precious Metals
- Sector
- ACHV Health Care
- VOXR Basic Materials
- Exchange
- ACHV Nasdaq
- VOXR Nasdaq
- Market Cap
- ACHV 126.9M
- VOXR 128.1M
- IPO Year
- ACHV N/A
- VOXR N/A
- Fundamental
- Price
- ACHV $3.17
- VOXR $2.38
- Analyst Decision
- ACHV Strong Buy
- VOXR
- Analyst Count
- ACHV 5
- VOXR 0
- Target Price
- ACHV $14.80
- VOXR N/A
- AVG Volume (30 Days)
- ACHV 229.0K
- VOXR 123.4K
- Earning Date
- ACHV 03-27-2025
- VOXR 02-20-2025
- Dividend Yield
- ACHV N/A
- VOXR 1.68%
- EPS Growth
- ACHV N/A
- VOXR N/A
- EPS
- ACHV N/A
- VOXR N/A
- Revenue
- ACHV N/A
- VOXR $11,047,763.00
- Revenue This Year
- ACHV N/A
- VOXR N/A
- Revenue Next Year
- ACHV N/A
- VOXR $2.02
- P/E Ratio
- ACHV N/A
- VOXR N/A
- Revenue Growth
- ACHV N/A
- VOXR N/A
- 52 Week Low
- ACHV $2.84
- VOXR $1.81
- 52 Week High
- ACHV $5.59
- VOXR $3.24
- Technical
- Relative Strength Index (RSI)
- ACHV 44.06
- VOXR 46.10
- Support Level
- ACHV $3.18
- VOXR $2.45
- Resistance Level
- ACHV $3.59
- VOXR $2.63
- Average True Range (ATR)
- ACHV 0.21
- VOXR 0.13
- MACD
- ACHV 0.01
- VOXR 0.00
- Stochastic Oscillator
- ACHV 19.48
- VOXR 28.57
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About VOXR Vox Royalty Corp.
Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of over 60 royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector.